Zusammenfassung
Man unterscheidet aktuell 228 Formen von Kopfschmerz, unterteilt in 14 Unterkapitel. Ein sehr großer Anteil an Kopfschmerzen kann alleine durch ein ausführliches Anamnese-Gespräch diagnostiziert oder in Richtung einer bestimmten Kopfschmerzform eingeengt werden. Bei neuen Symptomen oder Veränderung bestehender Symptome muss auch bei jahrelanger Kopfschmerzanamnese eine neuerliche Diagnostik durchgeführt werden! Von größter Bedeutung ist die Differenzierung zwischen primären und sekundären Kopfschmerzen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Wir bedanken uns bei Herrn Dr. Martin Pinsger, Facharzt für Orthopädie und orthopädische Chirurgie, Bad Vöslau und Privatklinik Josefstadt, Wien, für seinen Erfahrungsbericht mit lokaler Opioidanalgesie
Literatur
Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J (1999) Effect of inhibition of nitiric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999; 353: 287–289
Bartolini M, Silvestrini M, Taffi R, Lanciotti C, Luconi R, Capecci M, Provinciali L (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 2005; 28(6): 277–279
Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55: 19–26
Calhoun AH et al. (2010) The Prevalence of Neck Pain in Migraine. Headache 2010; 50: 1273
Chang Cl, Donaghy M, Poulter N (1999) Migraine and stroke in young women: case-control study: The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormon Contraceptation. BMJ 1999, 318: 13–18
Descombes S, Brefel-Courbon C, Thalamas C, Albucher JF, Rascol O, Montastruc JL, Senard J M (2001) Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headach 2001; 41: 178–182
Diener HC, Dodick DW, Aurora SK et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 Jul; 30(7): 804–14
Dowson AJ, Dodick DW, Limmroth V (2005) Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 2005; 19(6): 483–97
Edwards KR, Norton J, Behnke M (2001) Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001; 41: 976–80
Evers S, Gralow I, Bauer B, Suhr B, Buchheister A, Husstedt IW, Ringelstein EB (1999) Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 1999; 22: 201–206
Ferrari MD (1999) How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence. Cephalalgia 1999; 19 Suppl 23: 2–8
Fogelholm R, Murros K (1992). Tizanidine in chronic tension-type headache: a placebo controlled, double-blind cross over study. Headache 1992; 32: 509–513
Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 2001; 41(3): 271–278
Frietsche G, Diener H (2002) Medication overuse headaches – what is new? Expert Opin Drug Saf 1(4): 331–338
Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008; 372: 2115–2123
Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic anti-depressant medication, stress management therapy and their combination. JAMA 2001; 285: 2208–2215
Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 1999; 19: 602–621
Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000; 40: 818–823
Katsarava Z, Jensen R (2007) Medication overuse headache: where are we now? Curr Opin Neurol 2007; 20: 326–330
Knapp TW (1983) Migräne Bd. 1: Symptomatologie und Ätiologie. Beltz, Weinheim
Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ (2004) Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004; 127: 220–30
Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C (2005) BOTOX CDH Study Group. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005; 45(4): 293–307
Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005; 3
Olesen J, Bousser MG, Diener H et al. (2004) The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004; 24 (Suppl 1): 1–160
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ, for the Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26(6): 742–746
Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ (2006) Medication-overuse headache in patients with cluster headache. Neurology 67(1): 109–13
Panksepp J (1998) Affective Neuroscience: The Foundations of Human and Animal Emotions. New York: Oxford University Press
Patel NV, Bigal ME, Kolodner KB (2004) Prevalence and inpact of migraine and probable migraine in a health plan. Neurology 27: 163–181
Penzien DB, Rains JC, Andrasik F (2002) Behavioral management of recurent headache: three decades of experience empiricism. Appl Psychophhysiol Biofeedback 27: 948–951
Peres MF, Silberstein SD, Nahmias S, Shechter AL, Youssef I, Rozen TD, Young WB (2000) Hemicrania continua is not that rare. Neurology 2000; 57(6): 948–51
Rasmusen BK (1993) Migraine and tension typ headache in a general population: precipitating factors, female hormones, sleep pattern and relation to life-style. Pain 1993; 53: 65–72
Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44: 1147–1157
Russel MB (2004) Epidemiology and genetics of cluster headache. Lancet Neurol 2004; 3: 279–283
Russell MB (2011) Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine. J Headache Pain. 2011 Apr; 12(2): 135–6
Sacks O (1996) Migräne. 8. Aufl., Rororo: Rowohlt: Berlin
Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F (2003) Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study The Lancet, Volume 361, Issue 9374, 14 June 2003, pp. 2046–2048
Seng EK, Holroyd KA (2012) Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial. Cephalalgia. 2012; 32(5): 390–400
Serra G, Marchioretto F (2012) Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician. 2012; 15: 245–53
Shapiro RE, Tepper SJ (2007) The Serotonin Syndrome, Triptans, and the Potential for Drug-Drug Interactions, Headache 2007; 47: 266–69
Silberstein SD et al. (2005) Tramadol/Acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial. Headache 2005; 45: 1317–1327
Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L (2006) Topiramate in the treatment of chronic migraine. Cephalalgia 2003; 23(8): 820–4
Sjaastad O, Stovner LJ, Stolt Nielsen A, Antonaci F, Fredriksen TA (1995) CPH and hemicrania continua: requirements of high indomethacin dosages – an ominous sign? Headache 1995; 35(6): 363–367
Spierings ELH, Ranke AH, Schroevers M, Honkoop PC (2000) Chronic daily headachea time perspective. Headache 2000; 40: 306–310
Spira PJ, Beran RG (2003) Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 2003; 61(12): 1753–9
Stein A et al. (1999) Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999; 83: 525–32
Stovner LJ et al. (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193–210
Türp JC, Marinello CP (2002) Schmerzfragebogen für Patienten mit chronischen orofacialen Schmerzen. Quintessenz 29´002; 52: 1333–1340
Wiesinger B, Malker H, Englund E, Wänman A (2009) Does a dose-response relation exist between spinal pain and temporomandibular disorders? BMC Musculoskelet Disord 2009; 10: 28
Wöber C (2013) Migräne – was ist neu, was ist relevant? Ärztekrone, 2: 35–36
Wright EF (2000) Referred craniofacial pain patterns in patients with temporomandibular disorder. J Am Dent Assoc 2000; 131: 1307–1315
Zebenholzer K, Rudel E, Frantal S, Brannath W, Schmidt K, Wöber-Bingöl C, Wöber C (2011) Migraine and weather: A prospective diary-based analysis. Cephalalgia vol. 31; 4: 391–400
Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J (2004) Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004; 62(9): 1540–4
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Sendera, M., Sendera, A. (2015). Kopfschmerz. In: Chronischer Schmerz. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1841-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1841-2_7
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1840-5
Online ISBN: 978-3-7091-1841-2
eBook Packages: Medicine (German Language)